SERPINA1 and chronic obstructive pulmonary disease: A total of 86 individuals were recruited: 36 with COPD and normal AAT levels, 20 patients with COPD and AATD (Pi*ZZ), of whom 11 were on augmentation therapy, and 30 healthy controls.